Serum E-selectin and beta 2-microglobulin levels in Behçet's disease

Area of Science:

• Immunology and Rheumatology
• Vascular Biology

Background:

• Behçet's disease is a systemic vasculitis with an unknown cause.
• Endothelial cell injury is implicated in vasculitis pathogenesis, suggesting an immunopathogenic basis for Behçet's disease.
• E-selectin indicates endothelial injury, and beta 2-microglobulin (beta 2M) is elevated in immune disorders.

Purpose of the Study:

• To investigate serum concentrations of E-selectin and beta 2-microglobulin in patients with active Behçet's disease.
• To compare these marker levels with those in healthy controls.
• To assess the potential of these markers as indicators of Behçet's disease activity.

Main Methods:

• Serum samples were collected from 40 patients with active Behçet's disease and 40 healthy controls.
• E-selectin levels were measured using enzyme-linked immunosorbent assay (ELISA).
• Beta 2-microglobulin (beta 2M) levels were determined via nephelometry.

Main Results:

• Mean serum E-selectin concentration was 122.13 +/- 62.32 ng/ml in patients versus controls.
• Mean serum beta 2-microglobulin (beta 2M) concentration was 0.31 +/- 0.05 mg/dl in patients versus controls.
• Both E-selectin and beta 2M levels were significantly higher in Behçet's disease patients compared to healthy controls.

Conclusions:

• Elevated serum E-selectin and beta 2-microglobulin suggest endothelial injury and immune system involvement in Behçet's disease.
• These findings indicate that E-selectin and beta 2M may serve as potential biomarkers for Behçet's disease activity.
• Further comprehensive studies are required to validate their utility in clinical practice.